Asia: Food, Drugs, Healthcare, Life Sciences

Ministerial Direction 105 allows the government to issue instructions to Home Affairs on how skilled visas should be prioritised, typically taking into account regional needs, sponsorship status and critical sectors.

The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.

A coronial inquest into the death of Simon Gaskill reveals critical failures in hospital discharge planning for homeless patients with complex health needs. The case examines how standard discharge procedures failed to account for the practical realities of homelessness, leaving a vulnerable patient without meaningful access to follow-up care.

For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers.

The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.

China's National Intellectual Property Administration has launched a comprehensive 2026 nationwide patent survey targeting approximately 13,000 patent holders and 40,000 valid patents across 27 provinces. The survey will examine patent creation, protection, utilization, commercialization rates, infringement cases, high-value compensation, industry-academia collaboration, and overseas patent activities to inform intellectual property policy development.

For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers.

Thailand's Food and Drug Administration has published its first consolidated list of substances that have completed safety assessments, including novel foods and non-novel ingredients. This development provides unprecedented transparency into regulatory precedents while raising important questions about data exclusivity and the scope of applicant-specific approvals in the evolving landscape of food innovation.

The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.